Relevant bibliographies by topics / Immune booster

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Immune booster'

Author: Grafiati
Published: 2 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Immune booster.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Immune booster"

1

Dashputra, Amruta Vishwas, Nayse Jaydeep, Siddique R, Amit Date, and Quazi Shadama. "Perception and preference of health care providers regarding protective role of immunity boosters against Covid -19." Panacea Journal of Medical Sciences 13, no. 1 (2023): 103–8. http://dx.doi.org/10.18231/j.pjms.2023.022.

Full text
Abstract:
Covid -19 caused by a virus to which the people with low immunity response are being affected. Immune boosters play a vital role in protecting human being from various infective organism. The immune boosters include vitamins, minerals, antioxidants, probiotics etc. Indian Government gave emphasis on improving immunity in March 2020. At That time many people started using immunity booster agents. : To study perception and preference of medical teachers about immunity booster agents against Covid -19. A questionnaire based cross sectional study was conducted among medical teachers. Questionnaire
APA, Harvard, Vancouver, ISO, and other styles
2

HK, Singhal. "Suvarnaprashan: An Ayurvedic Immune Booster." Journal of Natural & Ayurvedic Medicine 5, no. 3 (2021): 1–4. http://dx.doi.org/10.23880/jonam-16000325.

Full text
Abstract:
The word 'Suvarnaprashan', a logical offshoot of Ayurveda, is made with combination of two words 'Suvarna' and 'Prashan'. The term Suvarna is a common word which refers to the Gold noble metal. Prashan refers to Pra+Ashan which means specially the act of eating or drinking or in taking. Suvarnaprashan has been practiced since a long back to make Vyadhikshamatva i.e. Immunity stronger to prevent infectious diseases as well as maintenance of good physical and mental growth and development of a child. According to WHO, Health is a state of complete physical, mental and social wellbeing and not me
APA, Harvard, Vancouver, ISO, and other styles
3

Hall, Jesse M., Kyle J. Caution, Yan Yuan, et al. "Characterizing the cellular and humoral immune responses to Tdap during pregnancy compared to non-pregnant controls." Journal of Immunology 210, no. 1_Supplement (2023): 252.06. http://dx.doi.org/10.4049/jimmunol.210.supp.252.06.

Full text
Abstract:
Abstract Maternal Tdap vaccination during pregnancy is recommended to protect infants from pertussis, pre-vaccination. However, it is unclear whether maternal immune responses improve following Tdap booster. We present analysis of immune responses pre- and post-Tdap booster, of pregnant women (Pw) primed by whole cell vaccines, who received Tdap booster during pregnancy, compared to Tdap boosted non-pregnant women (NPw). Tdap antigen specific serum antibody reactivity and avidity increased following booster in both groups. Reactivity and avidity were higher in NPw compared to Pw. Activation-in
APA, Harvard, Vancouver, ISO, and other styles
4

Handayani, Ety Sari, and Nurul Hidayah. "Heterologous Booster Profiles for Recipeints of CoronaVac Inactivated Primary Vaccine: A Scoping Review." Indonesian Journal of Clinical Pharmacy 12, no. 1 (2024): 68–85. https://doi.org/10.15416/ijcp.2023.12.1.68.

Full text
Abstract:
The administration of booster vaccines has been implemented in a number of countries. Unfortunately, there are limited studies of the immune response after booster to recipient with CoronaVac inactivated primary vaccine. This scoping review aims to determine heterologous booster profiles for recipients of the CoronaVac inactivated primary vaccine. This study obtained data from PubMed, Cochrane Library, Medrxiv, Google Scholar and Grey literature. The inclusion criteria were Sars-Cov-2 article, heterologous boosters and CoronaVac vaccine published from 2020 to 2022, written in English, and in a
APA, Harvard, Vancouver, ISO, and other styles
5

Violán, Concepció, Bibiana Quirant-Sánchez, Maria Palau-Antoja, et al. "Immune Durability and Breakthrough Infections 15 Months After SARS-CoV-2 Boosters in People over 65: The IMMERSION Study." Vaccines 13, no. 7 (2025): 738. https://doi.org/10.3390/vaccines13070738.

Full text
Abstract:
Background: SARS-CoV-2 booster vaccination remains essential to prevent severe COVID-19, particularly in vulnerable populations such as older adults. This study evaluated the durability and dynamics of immune responses following booster vaccination(s) in >65-year-old individuals and examined their association with protection against new infections. Methods: Immune responses were evaluated at 3, 9, and 15 months post-booster, measuring SARS-CoV-2-specific IgG antibodies against spike [IgG(S)] and nucleocapsid [IgG(N)] proteins, neutralizing activity against the Omicron BA.2 variant, and cell
APA, Harvard, Vancouver, ISO, and other styles
6

Ashrafian, Fatemeh, Fahimeh Bagheri Amiri, Anahita Bavand, Mahsan Zali, Mona Sadat Larijani, and Amitis Ramezani. "A Comparative Study of Immunogenicity, Antibody Persistence, and Safety of Three Different COVID-19 Boosters between Individuals with Comorbidities and the Normal Population." Vaccines 11, no. 8 (2023): 1376. http://dx.doi.org/10.3390/vaccines11081376.

Full text
Abstract:
Data on immunogenicity, immune response persistency, and safety of COVID-19 boosters in patients with comorbidities are limited. Therefore, we aimed to evaluate three different boosters’ immunogenicity and safety in individuals with at least one underlying disease (UD) (obesity, hypertension, and diabetes mellitus) with healthy ones (HC) who were primed with two doses of the BBIBP-CorV vaccine and received a booster shot of the same priming vaccine or protein subunit vaccines, PastoCovac Plus or PastoCovac. One hundred and forty subjects including sixty-three ones with a comorbidity and sevent
APA, Harvard, Vancouver, ISO, and other styles
7

Zhang, Zhiren, Qiaren He, Wei Zhao, et al. "A Heterologous V-01 or Variant-Matched Bivalent V-01D-351 Booster following Primary Series of Inactivated Vaccine Enhances the Neutralizing Capacity against SARS-CoV-2 Delta and Omicron Strains." Journal of Clinical Medicine 11, no. 14 (2022): 4164. http://dx.doi.org/10.3390/jcm11144164.

Full text
Abstract:
Immune escape of emerging SARS-CoV-2 variants of concern (VOCs) and waning immunity over time following the primary series suggest the importance and necessity of booster shot of COVID-19 vaccines. With the aim to preliminarily evaluate the potential of heterologous boosting, we conducted two pilot studies to evaluate the safety and immunogenicity of the V-01 or a bivalent V-01D-351 (targeting Delta and Beta strain) booster after 5–7 months of the primary series of inactivated COVID-9 vaccine (ICV). A total of 77 participants were enrolled, with 20 participants in the V-01D-351 booster study,
APA, Harvard, Vancouver, ISO, and other styles
8

Alhit, Hazim Abdul Rahman. "COVID Booster Shot and the Third Dose." Journal of Medical Research and Surgery 2, no. 6 (2021): 1. http://dx.doi.org/10.52916/jmrs204065.

Full text
Abstract:
The protection provided by the original shot(s) has begun to decrease over time, then a Coronavirus Disease (COVID) booster shot is given. Moreover, the immunity from the initial dose(s) naturally starts to wane, and you would get a booster. Accordingly, the booster is designed in order to maintain the people’s level of immunity for longer [1]. There is evidence that the effect of the vaccine wanes over time, so the officials recommended booster shots for everyone who is eighteen and older [2]. Therefore, the medics instructed the third dose for individuals who are immuno-compromised. The thir
APA, Harvard, Vancouver, ISO, and other styles
9

Alhit, Hazim Abdul Rahman. "COVID Booster Shot and the Third Dose." Journal of Medical Research and Surgery 2, no. 6 (2021): 1. http://dx.doi.org/10.52916/jmrs214065.

Full text
Abstract:
The protection provided by the original shot(s) has begun to decrease over time, then a Coronavirus Disease (COVID) booster shot is given. Moreover, the immunity from the initial dose(s) naturally starts to wane, and you would get a booster. Accordingly, the booster is designed in order to maintain the people’s level of immunity for longer [1]. There is evidence that the effect of the vaccine wanes over time, so the officials recommended booster shots for everyone who is eighteen and older [2]. Therefore, the medics instructed the third dose for individuals who are immuno-compromised. The thir
APA, Harvard, Vancouver, ISO, and other styles
10

Jaggaiahgari, Shashidhar, Apoorva Munigela, Sasikala Mitnala, Deepika Gujjarlapudi, Venu Simhadri, and Nageshwar Reddy D. "Heterologous Booster Dose with CORBEVAX Following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2." Vaccines 10, no. 12 (2022): 2146. http://dx.doi.org/10.3390/vaccines10122146.

Full text
Abstract:
Despite effective vaccination programs, waning immunity in the vaccinated populations and the emergence of variants of concern posed a risk of breakthrough infections. A booster dose was demonstrated to provide substantially increased protection against symptomatic disease and hospitalization. We aimed to evaluate immune memory and the efficacy of reducing the rate of SARS-CoV-2 infection post heterologous booster with CORBEVAX after primary vaccination with two doses of COVISHIELD. SARS-CoV-2 S1/S2 spike IgG and RBD-specific antibody responses were elicited with both booster vaccines, with a
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Immune booster"

1

Patel, Neil Pradip. "Investigating strategies to boost cutaneous varicella zoster virus-specific immune responses in ageing humans." Thesis, University College London (University of London), 2018. http://discovery.ucl.ac.uk/10055254/.

Full text
Abstract:
The age-related decline in the immune system, known as immunosenescence, predisposes old individuals to increased mortality and morbidity from infectious diseases (such as shingles, caused by reactivation of varicella zoster virus, VZV) and is associated with impaired vaccine responses. While multiple age-related changes have been identified in circulating memory T cells, little is known about the effects of ageing on memory T cells within peripheral tissues. T cells within human skin were characterised, and surprisingly neither their numbers, differentiation markers or effector functions were
APA, Harvard, Vancouver, ISO, and other styles
2

Yaseen, Ragheda [Verfasser]. "Exploring natural products to boost the host innate immune system against bacterial infections / Ragheda Yaseen." Hannover : Stiftung Tierärztliche Hochschule Hannover, 2018. http://d-nb.info/1202774776/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Caproni, Elena. "Distinctive innate immune signatures at injection site boost the adaptive response to flu subunit vaccine." Doctoral thesis, Università degli studi di Padova, 2011. http://hdl.handle.net/11577/3427448.

Full text
Abstract:
Vaccine adjuvants activate specific innate immune pathways which boost the adaptive responses to co-administered antigens. Experimental data in mouse and human have shown that the efficacy of vaccine adjuvants is often antigen-dependent. For example, alum has been used for years as an efficient adjuvant for many subunit vaccines including Hepatitis B and Diphteria-Tetanus, but is not very efficient in enhancing the response to flu HA antigen. Recently, several human studies have shown that oil-in-water emulsions such as MF59 are superior to alum in enhancing the response to flu subunit vaccin
APA, Harvard, Vancouver, ISO, and other styles
4

Philosof, Bar. "A bacterium from the human microbiota as a vaccine vector. Efficient priming of the murine immune system by vaginal delivery of recombinant Streptococcus gordonii." Doctoral thesis, Università di Siena, 2022. http://hdl.handle.net/11365/1216735.

Full text
Abstract:
The ability to prime the immune system against an antigen, and to rapidly recall this response upon antigen reencounter is a fundamental characteristic of the adaptive immune response. The association of an antigen recognized by the immune system in a certain tissue, with the same antigen encountered at a later timepoint in a different tissue, is of primary importance to obtain a systemic and effective immune response and is the foundation behind the utilization of vaccines. The study of vaccine delivery platforms that may activate the immune system in such a manner is therefore of primary imp
APA, Harvard, Vancouver, ISO, and other styles
5

Humby, Samantha A. "An investigation of the effects of helminth worm infection on the capacity of HIV vaccines to boost vaccine-generated immune responses." Master's thesis, University of Cape Town, 2017. http://hdl.handle.net/11427/24896.

Full text
Abstract:
To protect against sexual transmission, successful future HIV vaccines will likely be given to adolescents as a booster subsequent to primary immunization during infancy. In sub-Saharan Africa (SSA), a large proportion of children are chronically infected with a variety of helminths. These infections may suppress the ability of a host to elicit vaccine-induced Th1 responses that are considered important for a successful HIV vaccine. This study investigated the effect of chronic helminthic infection on the boosting capacity of a poxvirus-protein HIV vaccine regimen (SAAVI MVA-C and Env gp140 pr
APA, Harvard, Vancouver, ISO, and other styles
6

Searle, Benjamin James. "Characterisation of heterologous prime-boost vaccination strategies : an investigation into the nature and delivery of vaccines and the subsequent generation of immune responses." Thesis, University of Glasgow, 2004. http://theses.gla.ac.uk/2779/.

Full text
Abstract:
This thesis describes work undertaken to consider how strategies of vaccination can be manipulated to generate specific types and magnitude of immune response to prevent infection or treat established infection. The vaccination strategies employed were based on the initial delivery of DNA vaccine through intramuscular injection or ballistic delivery using a gene gun, followed by heterologous boosts, based on the same antigen delivered using an alternative route. These boost strategies included a) intramuscular delivery of purified recombinant HBcAg, b) mucosal delivery of HBcAg expressed by an
APA, Harvard, Vancouver, ISO, and other styles
7

Dubreil, Chloé. "Nanoparticules tolérogènes pour l’administration d’un auto-antigène des cellules bêta dans le diabète auto-immun Tolerogenic iron oxide nanoparticles in type 1 diabetes: biodistribution and pharmacokinetics studies in nonobese diabetic mice Tolerogenic nanoparticles boost regulatory B cells to reverse autoimmune diabetes." Thesis, Sorbonne Paris Cité, 2018. http://www.theses.fr/2018USPCB141.

Full text
Abstract:
Les maladies auto-immunes chroniques sont la conséquence de la reconnaissance par le système immunitaire d'auto-antigènes comme élément étranger, entraînant une destruction des tissus et organes cibles. Le diabète de type 1 (DT1), la maladie auto-immunes chronique la plus courante, est caractérisé par un insuffisance en insuline due à la destruction sélective des cellules bêta productrices d'insuline. Lors de l'apparition des signes cliniques, plus de 70% de la masse des cellules bêta peut être détruite. Par conséquent, le diagnostic précoce est un objectif majeur afin de limiter l'agression a
APA, Harvard, Vancouver, ISO, and other styles
8

Estcourt, Marie Joanne. "Studies on the immunobiology of prime-boost immunisation." Phd thesis, 2001. http://hdl.handle.net/1885/146092.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Tsele, Tebogo. "Questionnaire survey to determine the perceived effect of immune boosters on HIV/AIDS patients in South Africa." Thesis, 2008. http://hdl.handle.net/10210/926.

Full text
Abstract:
The joint United Nations programme on HIV/AIDS (UNAIDS) in collaboration with the World health Organization (WHO) published a report stating that, 42 million people are living with Human Immunodeficiency Virus (HIV) globally, where 20 million people had already died and where HIV, the virus that causes Acquired Immune Deficiency Syndrome continued to spread in all countries (Pratt, 2003). In South Africa it is estimated that a total number of 5.6 million individuals have acquired HIV infection by the end of 2003 (Department of Health, 2004). Highly active antiretroviral treatment (HAART) is pr
APA, Harvard, Vancouver, ISO, and other styles
10

Wu, Fan. "Evaluation of mucosal T cell immunity following HIV-1 prime-boost immunization." Master's thesis, 2010. http://hdl.handle.net/1885/151293.

Full text
Abstract:
Vaccination is one of the most important contributions to human health and has produced a dramatic reduction in infectious disease deaths over the last 100 years. However, there is still no successful vaccine for HIV-1 that provides full protection against infection. Because HIV-1 primarily infects the mucosae, there is strong opinion that more effective mucosal HIV-1 vaccines eliciting robust immunity at mucosal sites will be a key requirement for a successful vaccine. This thesis evaluates mucosal HIV-specific CD8{u207A} T cell responses following prime-boost immunization with a novel HIV-1
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Immune booster"

1

(Firm), Hamlyn, ed. Immune boosters. Hamlyn, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Wade, Carlson. How to beat arthritis with immune power boosters. Prentice Hall, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wade, Carlson. Immune power boosters: Your key to feeling younger, living longer. Prentice Hall, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Francis-Cheung, Theresa. 100 ways to boost your immune system. Collins, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

von, Lühmann Manfred, ed. Conscious healing: Visualizations to boost your immune system. Bantam Books, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Levy, Elinor. The ten best tools to boost your immune system. Houghton Mifflin, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Longbotham, Lori. Quick and easy recipes to boost your immune system. Avon Books, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Jennifer, Meek, ed. Boost your immune system: The drug-free guide to fighting infection and preventing disease. Piatkus, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Maya, Pines, and Howard Hughes Medical Institute, eds. Arousing the fury of the immune system: New ways to boost the body's defenses. Howard Hughes Medical Institute Office of Communications, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Pugliese, Peter T. Devour disease with shark liver oil: Breakthrough discovery can help boost your immune system. IMPAKT Communications, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Immune booster"

1

Valencia-Hernández, Leidy Johana, Juan Alberto Ascacio-Valdés, Jorge Enrique Wong-Paz, Haroon Khan, and Cristóbal N. Aguilar. "Immune Booster Property of Epigallocatechin-3-Gallate and Catechin." In Nutraceuticals and Functional Foods in Immunomodulators. Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-2507-8_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Pandey, Saumya. "Potential of Medicinal Plants as Immunity Booster against COVID-19." In Traditional Herbal Therapy for the Human Immune System. CRC Press, 2021. http://dx.doi.org/10.1201/9781003137955-16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ghosh, Pritha, and Subhadeep Dutta. "Effectiveness of Flax Seed, an Immune Booster Functional Food during COVID-19 Pandemic Situation." In Immunity Boosting Functional Foods to Combat COVID-19. CRC Press, 2021. http://dx.doi.org/10.1201/9781003242604-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kröger, Nicolaus, and Nico Gagelmann. "Prevention and Treatment of Relapse by Drugs." In The EBMT Handbook. Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-44080-9_58.

Full text
Abstract:
AbstractRelapse has become the most frequent cause of treatment failure after HCT (Horowitz et al. 2018). Because outcome after relapse remains poor, major efforts are focused on prevention of relapse. Beside adoptive cell-based options, such as DLI and CAR T cells, the availability of novel effective pharmacological compounds has opened new avenues in clinical research to use those drugs early after HCT in order to prevent and treat relapse (Kroger et al. 2014). The optimal pharmacological compound should have a safe toxicity profile, an antitumor effect to the underlying disease, and an immu
APA, Harvard, Vancouver, ISO, and other styles
5

Renneberg, Reinhard, and Iris Rapoport. "Immun-Booster S-Bahn." In Bio, Biio, Biiio! Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-58188-9_52.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Morrison, Hazel, and Helen McShane. "BCG: Past, Present and Future Direction." In Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-24355-4_8.

Full text
Abstract:
AbstractBacillus Calmette-Guérin (BCG) is a live-attenuated vaccine developed over 100 years ago and remains the only vaccine ever licensed in the fight against tuberculosis (TB). It is one of the most widely used vaccines in the world, having been administered to over four billion people, with another 100 million children vaccinated with BCG every year. Despite this, significant debate exists surrounding its efficacy against TB and its place in routine infant vaccination schedules. Severe side effects following BCG administration are rare but may be seen in those with immune system dysfunctio
APA, Harvard, Vancouver, ISO, and other styles
7

Mishra, Siddhartha Kumar, Pir Mohammad Ishfaq, Swati Tripathi, and Neelima Gupta. "Fruits as Boosters of the Immune System." In Plants and Phytomolecules for Immunomodulation. Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-8117-2_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Agarwal, Swati, Sonu Kumari, and Amrendra Kumar. "Natural Immunity Boosters and Anticancer Medicinal Plants." In Traditional Herbal Therapy for the Human Immune System. CRC Press, 2021. http://dx.doi.org/10.1201/9781003137955-15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Suja, S. R., N. M. Krishnakumar, B. S. Bijukumar, and R. Prakashkumar. "Bioactive Flavonoids from Natural Sources: Potential Immune-Boosters." In Flavonoids as Nutraceuticals. Apple Academic Press, 2024. http://dx.doi.org/10.1201/9781003412441-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

London, Calvin. "Functional Foods that Boost the Immune System." In Functional Food Product Development. Wiley-Blackwell, 2010. http://dx.doi.org/10.1002/9781444323351.ch14.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Immune booster"

1

Chu, Chien-Wei, Min-Der Lin, and Kang-Ting Tsai. "Optimal Scheduling of Booster Chlorination with Immune Algorithm." In 2008 Third International Conference on Convergence and Hybrid Information Technology (ICCIT). IEEE, 2008. http://dx.doi.org/10.1109/iccit.2008.411.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Tjandrawati, Caroline, Mary Geannel Cabahug, Debora Magdalena Palele, and Ferbian Ferbian. "Physical Exercises: Immune System Booster During the COVID-19 Pandemic." In 3rd Tarumanagara International Conference on the Applications of Social Sciences and Humanities (TICASH 2021). Atlantis Press, 2022. http://dx.doi.org/10.2991/assehr.k.220404.316.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Yakovlev, V. A., M. B. Borgoyakova, E. V. Tigeeva, D. N. Kisakov, L. A. Kisakova, and L. I. Karpenko. "BOOSTER IMMUNIZATION OF MICE WITH A CANDIDATE POLYEPITOPE DNA VACCINE USING JET INJECTION LEADS TO A SIGNIFICANT INCREASE IN THE T-CELL IMMUNE RESPONSE." In XI МЕЖДУНАРОДНАЯ КОНФЕРЕНЦИЯ МОЛОДЫХ УЧЕНЫХ: БИОИНФОРМАТИКОВ, БИОТЕХНОЛОГОВ, БИОФИЗИКОВ, ВИРУСОЛОГОВ, МОЛЕКУЛЯРНЫХ БИОЛОГОВ И СПЕЦИАЛИСТОВ ФУНДАМЕНТАЛЬНОЙ МЕДИЦИНЫ. IPC NSU, 2024. https://doi.org/10.25205/978-5-4437-1691-6-367.

Full text
Abstract:
The T-cell immune response is an important part of immunity against SARS-CoV-2. In this work, it was shown that the developed candidate DNA vaccine pBSI-COV-Ub has the ability to induce T-cell immunity in Balb/c mice. The immune response was most effectively stimulated by double intramuscular administration of the vaccine, followed by booster immunization using jet injection.
APA, Harvard, Vancouver, ISO, and other styles
4

Chieh Chen, Yu, Li Yun Wang, Chi Chih Chen, et al. "CD154 ELEVATING CELLULAR IMMUNITY BY UP-REGULATING THE PERCENTAGES OF ANTIGEN-SPECIFIC POSITIVE INTERFERON-GAMMA EXPRESSING CELLS." In Singapore International Conference on Research in Life-Science & Healthcare, 04-05 March 2025. Global Research & Development Services Publishing, 2025. https://doi.org/10.20319/icrlsh.2025.12.

Full text
Abstract:
CD154 plays a central role in the development and regulation of adaptive immune responses in mammals and thus may act as a potential molecular adjuvant due to its enhancement of cytokine expression in immune cells. In this study, CD154-coding sequence was linked with the E2 antigen sequence of the Classical swine fever virus (CSFV) to produce an E2-CD154 vaccine and the specific pathogen free piglets at the age of 4-week old was used as an animal model. The CpG adjuvant, a Toll-like receptor 9 agonist, was used as a positive control. The animals were randomized into three groups and primarily
APA, Harvard, Vancouver, ISO, and other styles
5

Pamantung, Rina P., and I. Nengah Sudipa. "The Names of Traditional Minahasan Food as Immune Booster in the Covid-19 Pandemic." In International Congress of Indonesian Linguistics Society (KIMLI 2021). Atlantis Press, 2021. http://dx.doi.org/10.2991/assehr.k.211226.049.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

HINKULA, JORMA, CLAUDIA DEVITO, BARTEK ZUBER, et al. "SYSTEMIC AND MUCOSAL IMMUNE RESPONSES INDUCED BY HIV-1 DNA AND HIV-PEPTIDE OR VLP BOOSTER IMMUNIZATION." In Fourth Centenary of the Foundation of the First Academy of Sciences: “Academia Lynceorum” by Federico Cesi and Pope Clemente VIII. WORLD SCIENTIFIC, 2004. http://dx.doi.org/10.1142/9789812702753_0027.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Barta, I., V. Schmidt, I. Mán, M. Valyon, L. Lőrinczi, and B. Antus. "Comparison of humoral immune responses to initial and booster SARS-CoV-2 vaccination among respiratory health professionals." In ERS International Congress 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/13993003.congress-2022.923.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Barta, Imre, Viktória Szél, Imola Mán, Lilla Lőrinczi, and Balázs Antus. "Comparison of the immune response of respiratory healthcare workers to booster vaccination against SARS-CoV-2 and to a subsequent viral infection." In ERS International Congress 2023 abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/13993003.congress-2023.pa3809.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Araújo, Vinícius Pacheco de, Matheus Diniz Teixeirense, Ana Beatriz Queiroz Teles, et al. "VACCINATION COVERAGE AND DETERMINANT FACTORS IN VACCINE HESITANCY TO COVID-19 BOOSTER DOSES IN PATIENTS WITH IMMUNE-MEDIATED RHEUMATIC DISEASES AND IMMUNOSUPPRESSION." In XLI Congresso Brasileiro de Reumatologia. Sociedade Brasileira de Reumatologia, 2024. https://doi.org/10.47660/cbr.2024.2157.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Cheng, Y. H., N. Kagi, A. Oyobe, and K. Nakamura. "Multichannel amplification characteristics of saturated erbium-doped fiber amplifiers." In Optical Amplifiers and Their Applications. Optica Publishing Group, 1991. http://dx.doi.org/10.1364/oaa.1991.thb2.

Full text
Abstract:
Erbium-doped fiber amplifiers (EDFAs) are attractive for various optical fiber transmission systems and networks owing to their several advantages such as high gain and low noise. A EDFA with its high output saturation power and wide gain profile is specially suitable for wavelength-division multiplexing (WDM) applications such as multichannel CATV distribution systems [1]. In these applications, the EDFA is normally used as a post (or a booster) amplifier and operates at a saturated region. Although it has been demonstrated that the EDFA is immune to patterning effects and interchannel interf
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Immune booster"

1

Juni, Peter, Ashleigh R. Tuite, Issac I. Bogoch, et al. Rollout Strategy for the Pfizer-BioNTech COVID-19 Vaccine in Ontario. Ontario COVID-19 Science Advisory Table, 2021. http://dx.doi.org/10.47326/ocsat.2021.02.06.1.0.

Full text
Abstract:
Administering Pfizer-BioNTech’s COVID-19 vaccine during the early stage of the vaccine rollout (January/February 2021) to as many individuals as possible would prevent more COVID-19 cases in Ontario as compared to reserving half of the initial allotments as second booster doses (Figure 1). On-label use of the vaccine with the administration of two doses is important, as the second dose significantly boosts the immune response and results in a substantial increase in neutralizing antibodies. However, using 100% of the initial allotments immediately to vaccinate as many individuals as possible d
APA, Harvard, Vancouver, ISO, and other styles
2

Xu, Junjie, Jiaye Liu, Xinquan Lan, Moxin Song, Liangyuan Zhang, and Jiaqi Zhang. Efficacy of the third dose of COVID-19 vaccine: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.11.0114.

Full text
Abstract:
Review question / Objective: To investigate the immune response and related clinical outcomes of healthy adults who received coronavirus vaccine booster compared with those who did not receive the vaccine booster. Condition being studied: The COVID-19 pandemic, which has spread since 2019, has created a huge disease and economic burden on the world. A large number of clinical trials have verified the effectiveness of COVID-19 vaccine. Previous studies have found that the serum conversion rate and antibody level of those vaccinated after the first two doses of COVID-19 vaccine continue to decre
APA, Harvard, Vancouver, ISO, and other styles
3

Gershoni, Jonathan M., David E. Swayne, Tal Pupko, et al. Discovery and reconstitution of cross-reactive vaccine targets for H5 and H9 avian influenza. United States Department of Agriculture, 2015. http://dx.doi.org/10.32747/2015.7699854.bard.

Full text
Abstract:
Research objectives: Identification of highly conserved B-cell epitopes common to either H5 or H9 subtypes of AI Reconstruction of conserved epitopes from (1) as recombinantimmunogens, and testing their suitability to be used as universal vaccine components by measuring their binding to Influenza vaccinated sera of birds Vaccination of chickens with reconstituted epitopes and evaluation of successful vaccination, clinical protection and viral replication Development of a platform to investigate the dynamics of immune response towards infection or an epitope based vaccine Estimate our ability t
APA, Harvard, Vancouver, ISO, and other styles
4

COVID-19 spring booster vaccine resources for people with a weakened immune system. Public Health Scotland, 2023. http://dx.doi.org/10.52487/124810.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

COVID-19 vaccine spring booster leaflet for people aged 5 and over with a weakened immune system - English. Public Health Scotland, 2023. http://dx.doi.org/10.52487/121788.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

A pause in methotrexate treatment boosted the immune response to the COVID-19 vaccine. National Institute for Health Research, 2023. http://dx.doi.org/10.3310/nihrevidence_56391.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Immune booster' for particular source types:
Journal articles Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography